1. Home
  2. Live Updates
  3. Karyopharm therapeutics

Live Breaking News & Updates on Karyopharm therapeutics

Stay informed with the latest breaking news from Karyopharm therapeutics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Karyopharm therapeutics and stay connected to the pulse of your community

Next-Gen PARP Inhibitor Shows Benefit in Breast Cancer Patients

Next-Gen PARP Inhibitor Shows Benefit in Breast Cancer Patients
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Oregon , United-states , Hong-kong , United-kingdom , Switzerland , Texas , Swiss , American , Haihe-biopharma , Biocity-biopharma , Calithera-biosciences , Terremoto-biosciences

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWTON, Mass., April 1, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an...

United-kingdom , China , Nasdaq , Prnewswire-karyopharm-therapeutics-inc , Karyopharm-therapeutics-inc , Selective-inhibitor-of-nuclear-export , Linkedin , Stock-incentive-plan , Nasdaq-listing-rule , Selective-inhibitor , Nuclear-export

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , China , Linkedin , Selective-inhibitor-of-nuclear-export , Prnewswire-karyopharm-therapeutics-inc , Nasdaq , Karyopharm-therapeutics-inc , Stock-incentive-plan , Nasdaq-listing-rule , Selective-inhibitor , Nuclear-export

Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript

KPTI earnings call for the period ending December 31, 2023.

United-states , Michael-mason , Jonathan-chang , Brian-abrahams , John-mascarenhas , Richard-paulson , Reshma-rangwala , Sohanya-cheng , Maury-raycroft , Joe-spak , Jonathan-chang-leerink , Peter-lawson

Earnings Scheduled For February 29, 2024 - Arbutus Biopharma (NASDAQ:ABUS), American Coastal (NASDAQ:ACIC)

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Blackrock , Nova-scotia , Canada , Toronto , Ontario , United-states , American , Canadian , Quaker-houghton , Dentsply-sirona , Everi-hldgs , Douglas-elliman

Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress

Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United-states , Boston , Massachusetts , Macau , Singapore , United-kingdom , Sadal , Kyongsang-bukto , South-korea , Seoul , Soult-ukpyolsi , Hong-kong

Karyopharm Therapeutics: Q4 Earnings Snapshot

NEWTON, Mass. (AP) — NEWTON, Mass. (AP) — Karyopharm Therapeutics Inc. (KPTI) on Thursday reported a loss of $41.8 million in its fourth quarter.

Massachusetts , United-states , Zacks-investment-research , Karyopharm-therapeutics-inc , Karyopharm-therapeutics , Wall-street ,

Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript

KPTI earnings call for the period ending December 31, 2023.

United-states , Jonathan-chang-leerink , Elhan-webb , Maury-raycroft-jefferies , Jonathan-chang , Brian-abrahams , Steve-bersey , John-mascarenhas , Joe-spak , Michael-mason , Sohanya-cheng , Maury-raycroft

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory

Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.

Boston , Massachusetts , United-states , Connecticut , Actinium-pharmaceuticals , National-institutes-of-health , View-research , Adicet-bio , Grand-view , Stoke-therapeutics , National-institutes

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory

InvestorPlace - Stock Market News, Stock Advice & Trading Tips While targeting the therapeutic side of the healthcare sector can be quite lucr...

Boston , Massachusetts , United-states , Connecticut , Gorodenkoff-shutterstock , Josh-enomoto , Danny-shutterstock , View-research , Sony-electronics , Actinium-pharmaceuticals , National-institutes-of-health , Adicet-bio